首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   956篇
  免费   62篇
  国内免费   9篇
耳鼻咽喉   5篇
儿科学   42篇
妇产科学   5篇
基础医学   115篇
口腔科学   44篇
临床医学   79篇
内科学   174篇
皮肤病学   58篇
神经病学   37篇
特种医学   164篇
外国民族医学   1篇
外科学   72篇
综合类   42篇
预防医学   61篇
眼科学   20篇
药学   76篇
中国医学   1篇
肿瘤学   31篇
  2021年   4篇
  2020年   7篇
  2019年   8篇
  2018年   14篇
  2017年   20篇
  2016年   16篇
  2015年   29篇
  2014年   21篇
  2013年   37篇
  2012年   33篇
  2011年   41篇
  2010年   35篇
  2009年   50篇
  2008年   33篇
  2007年   23篇
  2006年   27篇
  2005年   20篇
  2004年   31篇
  2003年   25篇
  2002年   11篇
  2001年   8篇
  2000年   9篇
  1999年   21篇
  1998年   55篇
  1997年   62篇
  1996年   56篇
  1995年   43篇
  1994年   40篇
  1993年   37篇
  1992年   8篇
  1991年   11篇
  1990年   17篇
  1989年   14篇
  1988年   22篇
  1987年   23篇
  1986年   21篇
  1985年   9篇
  1984年   4篇
  1983年   10篇
  1982年   18篇
  1981年   4篇
  1980年   9篇
  1979年   4篇
  1978年   4篇
  1977年   5篇
  1976年   6篇
  1975年   2篇
  1973年   2篇
  1968年   3篇
  1959年   2篇
排序方式: 共有1027条查询结果,搜索用时 15 毫秒
191.
A 64-year-old white man, who had never received a transfusion, was found to have anti-M in his serum. The antibody agglutinated all M+ red cells in room-temperature tests. When the ionic strength of the test milieu was reduced by use of an additive solution and the tests were incubated at 37 degrees C, the antibody hemolyzed M + N- but not M+N+ red cells. All M+ red cells reacted in indirect antiglobulin tests using polyspecific antiglobulin reagents when such tests followed an initial incubation at room temperature. When red cells and the patient's serum were warmed to 37 degrees C before being mixed, no antibody activity was demonstrable. The antibody was adsorbed to exhaustion onto M+N- and M+N+ red cells (including the patient's own), and its activity was destroyed by dithiothreitol. There was no evidence of in vivo red cell destruction by the autoantibody. No previously reported example of anti-M has been shown to activate complement in conventional in vitro tests. This example was extraordinary in that it caused sufficient complement activation to present as an in vitro hemolysin.  相似文献   
192.
193.
钙拮抗剂在心肌肥厚时对β受体阻滞剂撤药的影响   总被引:2,自引:0,他引:2  
用腹主动脉结扎4周引起的压力超负荷型左室肥厚大鼠,观察长期大剂量用美托洛尔(metoprolol,Met)突然撤药1d后的血流动力学变化、心肌β受体变化,及硝苯地平(nifedipine,Nif),间硝地平(m-nifedipine,m-Nif)对这些变化的影响。Nif和m-Nif在减轻心肌肥厚的同时,均可缓解Met撤药后平均动脉压和左室收缩压的异常增高,并可防止β受体的上调。本结果提示合用钙拮抗剂可预防β阻滞剂的撤药反应。  相似文献   
194.
Elastosis perforans serpiginosa (EPS) is a rare perforating dermatosis in which elastic fibers extrude from the papillary dermis producing umbilicated papules, characteristically arranged to form arciform or serpiginous patterns on the skin. It can be observed in patients with Down's syndrome, in whom in some cases the disease has been reported to be more widespread and to run a longer course. We present the case of a 20-year-old girl with Down's syndrome, hypothyroidism, acne and hypertrichosis, who had a 2-year history of multiple atrophic lesions with an arciform pattern on the distal extensor portions of both thighs, histologically showing the typical features of EPS.  相似文献   
195.
There is evidence that endogenous opioid peptides exert an inhibitory effect on pituitary luteinizing hormone (LH) secretion both in animals and in humans, by interacting with mu-opioid receptors. However, a role for delta-opioid receptors in the regulation of gonadotrophin releasing hormone (GnRH) secretion has recently been suggested. In the present study, we evaluated the effect of the highly selective delta-opioid receptor agonist deltorphin on the LH and follicle stimulating hormone (FSH) responses to naloxone in six healthy fertile women during the luteal phase of the menstrual cycle. Deltorphin infusion alone (7 microg/kg/min for 60 min) did not significantly change the basal serum concentrations of LH in this group of women. The intravenous (i.v.) bolus administration of naloxone (15 mg) induced a significant (P < 0.001) increase in serum LH concentrations (from a mean basal value of 4.24+/-1.10 IU/l to a peak of 13.27+/-1.8 IU/l). The LH response to naloxone was significantly (P < 0.001) blunted by preinfusion of deltorphin (13.27+/- 1.80 IU/l versus 4.80+/-1.18 IU/l). No significant changes in FSH concentrations were observed during deltorphin, naloxone or deltorphin plus naloxone administration. These data indicate that activation of delta-opioid receptors can reduce naloxone-induced LH release, suggesting a possible role of delta receptors in opioidergic modulation of LH secretion in women.   相似文献   
196.
197.
线性回归和叠代排除法在脑星形细胞瘤2D1H MRS中的应用   总被引:4,自引:3,他引:1  
目的 探讨Cho/NAA线性模型和叠代排除法区分脑星形细胞瘤的PROBE VOI内正常(参照)体素群、病变(排除)体素群的可行性,探讨星形细胞瘤中Cho/NAA残差Z积分分布图的意义。方法得出正常对照组和星形细胞瘤中正常(参照)体素群的Cho/HAA、Cho/Cr:得出星形细胞瘤和健康志愿者中病变(排除)体素群各体素的残差Z积分。结果 正常对照组和星形细胞瘤的正常(参照)体素群的Cho/NAA、Cho/Cr没有统计学差异;得出了Z-积分分布图。结论 Cho/NAA线性模型和叠代排除法能区分脑星形细胞瘤的正常(参照)体素群及病变(排除)体素群、Z积分图可获得生化代谢的分布信息。  相似文献   
198.
199.
A study was conduced in 100 migraine patients and 100 control subjects who did not suffer from headaches to test Dung's hypothesis that the number of painful spinal processes in the throacic spine can be used as a quantitative measure of the degree of pain in the patient concerned. The results show significant differences in the frequency of painful spinal processes between the two study groups. This supports Dung's hypotheses. As it is easy to determine the presence of painful spinal processes the frequency of this phenomenon, the reasons for it and its significance should be the sujbects of further examination.  相似文献   
200.

Background

Pazopanib is among the current standards of care for first-line treatment of patients with unresectable advanced renal-cell carcinoma (aRCC) or metastatic renal-cell carcinoma. This real-world study aimed to characterize those with long-term response to pazopanib in the treatment of aRCC in a community oncology setting, and to identify predictors of long-term response.

Patients and Methods

aRCC patients treated with first-line pazopanib were classified as having long-term or non–long-term response (progression-free survival [PFS] of ≥ 18 or < 18 months, respectively). Baseline patient demographics and clinical characteristics were evaluated and compared between the 2 groups. Differences in PFS and overall survival were also evaluated.

Results

A total of 153 eligible patients were identified, of which 33 (21.6%) and 120 (78.4%) patients were identified as having disease with long-term and non–long-term response, respectively. The median PFS for those with long-term response was 27.2 months (95% confidence interval [CI], 23.0-35.2) versus 6.9 months (95% CI, 5.0-8.6) for those with non–long-term response. Median overall survival was not reached (NR) for those with long-term response (95% CI, NR to 39.1) compared to 15.3 months (95% CI, 12.3-21.6) for those with non–long-term response. Baseline Eastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 (vs. ECOG PS of 1 and ≥ 2) and history of nephrectomy were identified as significant predictors of long-term response to pazopanib.

Conclusion

In aRCC patients treated with first-line pazopanib, 22% had a long-term response. Significant predictors of long-term response included an ECOG PS of 0 and a history of nephrectomy.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号